- Home
- HUDI vs ICCC Comparison
HUDI vs ICCC Comparison
Compare HUDI & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUDI
- ICCC
- Stock Information
- Founded
- HUDI 2018
- ICCC 1982
- Country
- HUDI China
- ICCC United States
- Employees
- HUDI N/A
- ICCC N/A
- Industry
- HUDI Steel/Iron Ore
- ICCC Biotechnology: Pharmaceutical Preparations
- Sector
- HUDI Industrials
- ICCC Health Care
- Exchange
- HUDI Nasdaq
- ICCC Nasdaq
- Market Cap
- HUDI 18.8M
- ICCC 60.1M
- IPO Year
- HUDI 2021
- ICCC 1987
- Fundamental
- Price
- HUDI $1.34
- ICCC $6.98
- Analyst Decision
- HUDI
- ICCC
- Analyst Count
- HUDI 0
- ICCC 0
- Target Price
- HUDI N/A
- ICCC N/A
- AVG Volume (30 Days)
- HUDI 14.7K
- ICCC 44.4K
- Earning Date
- HUDI 08-05-2025
- ICCC 08-12-2025
- Dividend Yield
- HUDI N/A
- ICCC N/A
- EPS Growth
- HUDI N/A
- ICCC N/A
- EPS
- HUDI 0.01
- ICCC N/A
- Revenue
- HUDI $74,270,429.00
- ICCC $27,302,766.00
- Revenue This Year
- HUDI N/A
- ICCC N/A
- Revenue Next Year
- HUDI N/A
- ICCC N/A
- P/E Ratio
- HUDI $136.20
- ICCC N/A
- Revenue Growth
- HUDI N/A
- ICCC 28.29
- 52 Week Low
- HUDI $1.26
- ICCC $3.34
- 52 Week High
- HUDI $3.45
- ICCC $7.60
- Technical
- Relative Strength Index (RSI)
- HUDI 41.31
- ICCC 55.17
- Support Level
- HUDI $1.35
- ICCC $5.63
- Resistance Level
- HUDI $1.44
- ICCC $7.55
- Average True Range (ATR)
- HUDI 0.08
- ICCC 0.54
- MACD
- HUDI -0.01
- ICCC -0.03
- Stochastic Oscillator
- HUDI 24.24
- ICCC 61.24
About HUDI Huadi International Group Co. Ltd.
Huadi International Group Co Ltd is a manufacturer of industrial stainless steel seamless pipes and tubes products. Its products are used in the oil & gas transmission, chemistry engineering, food processing, medical devices, aeronautics and astronautics, boiler, irrigation works construction, automobile and naval architecture, paper mill and mechanical industries. Company generates revenue from Sales of steel piping products. Products are exported to the United States, Mexico, Thailand, Singapore, Argentina, Taiwan, India, the Philippines, UAE and Canada. Geographically, majority revenue is generated from China.
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.